Cynapsus Therapeutic (CYNAF) 0.6100 $CYNAF First patient

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cynapsus Therapeutic (CYNAF) 0.6100 $CYNAF

First patient enrolled in late stage study of Cynapsus Therapeutics' Parkinson's candidate
Seeking Alpha - at Seeking Alpha - Mon Jun 29, 6:41AM CDT


Cynapsus Therapeutics Inc. : Announces Proposed Public Offering in the United States, Listing on NASDAQ and Share Consolidation
GlobeNewswire - Fri May 15, 4:33PM CDT
Cynapsus Therapeutics Inc. (TSX: CTH) (OTCQX: CYNAF) announced today the filing of a registration statement with the US Securities and Exchange Commission relating to a public offering in the United States of its common shares and the filing of an application to list on the NASDAQ Capital Market. The timing, number of shares and price per share of the proposed offering have not yet been determined. Cynapsus also announced an amendment to the Company's articles to consolidate the issued and outstanding common shares of the Company on the basis of one post-consolidation common share for 16 pre-consolidation common shares to facilitate the proposed listing on NASDAQ, as previously approved by the shareholders of the Company.
CTH.TO: 21.50 (+0.05)

Cynapsus Therapeutics Announces Proposed Public Offering in the United States, Listing on NASDAQ and Share Consolidation
Marketwired - Fri May 15, 4:29PM CDT
Cynapsus Therapeutics Inc. (TSX: CTH)(OTCQX: CYNAF) announced today the filing of a registration statement with the US Securities and Exchange Commission relating to a public offering in the United States of its common shares and the filing of an application to list on the NASDAQ Capital Market. The timing, number of shares and price per share of the proposed offering have not yet been determined. Cynapsus also announced an amendment to the Company's articles to consolidate the issued and outstanding common shares of the Company on the basis of one post-consolidation common share for 16 pre-consolidation common shares to facilitate the proposed listing on NASDAQ, as previously approved by the shareholders of the Company.
CTH.TO: 21.50 (+0.05)

Cynapsus Therapeutics Inc. : Reports First Quarter 2015 Financial Results and Recent Developments
GlobeNewswire - Fri May 08, 3:54PM CDT
Cynapsus Therapeutics Inc. (TSX: CTH) (OTCQX: CYNAF), a specialty Central Nervous System (CNS) pharmaceutical company developing and preparing to commercialize a fast-acting, easy-to-use sublingual thin film for the on-demand management of debilitating OFF episodes associated with Parkinson's disease (PD), today announced financial results for the three months ended March 31, 2015. Unless specified otherwise, all amounts are in Canadian dollars.
CTH.TO: 21.50 (+0.05)

Cynapsus Therapeutics Reports First Quarter 2015 Financial Results and Recent Developments
Marketwired - Fri May 08, 3:46PM CDT
Cynapsus Therapeutics Inc. (TSX: CTH)(OTCQX: CYNAF), a specialty Central Nervous System (CNS) pharmaceutical company developing and preparing to commercialize a fast-acting, easy-to-use sublingual thin film for the on-demand management of debilitating OFF episodes associated with Parkinson's disease (PD), today announced financial results for the three months ended March 31, 2015. Unless specified otherwise, all amounts are in Canadian dollars.
CTH.TO: 21.50 (+0.05)

Cynapsus Therapeutics Announces CAD$21 Million Private Placement
Business Wire - Tue Mar 31, 9:26AM CDT
Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on the treatment of OFF episodes in Parkinson's disease, today announced the completion of a private placement (the "Offering" of 22,039,472 common shares of the Company (the "Common Shares" for gross proceeds of CAD$20,981,579.
CTH.TO: 21.50 (+0.05)

Cynapsus Therapeutics Reports 2014 Annual Results
Business Wire - Tue Mar 17, 4:56PM CDT
Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on the treatment of OFF episodes in Parkinson's disease, today announced financial results for the year ended December 31, 2014. Unless specified otherwise, all amounts are in Canadian dollars.
CTH.TO: 21.50 (+0.05)

Cynapsus to Host Analyst and Investor Breakfast in New York City on March 18
Business Wire - Mon Mar 16, 5:00AM CDT
Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on Parkinson's disease, announced that it will host an Analyst and Investor Breakfast featuring presentations by executive management and a clinical key opinion leader on Wednesday, March 18, 2015 at 7:30 a.m. in New York City.
CTH.TO: 21.50 (+0.05)

Cynapsus Therapeutics Appoints Tamar Howson to Board of Directors
Business Wire - Thu Mar 12, 3:10PM CDT
Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on the treatment of OFF episodes in Parkinson's disease, today announced that Tamar Howson has been appointed to the Company's Board of Directors. With the addition of Ms. Howson to the Board of Directors, the Company now has eight directors, with seven directors classified as independent.
OXGN: 1.34 (unch), NPSP: 45.97 (+0.01), BMY: 59.22 (+0.47), CTH.TO: 21.50 (+0.05)

Cynapsus Therapeutics to start Phase 3 trial for Parkinson's drug in Q2
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 4:08PM CDT


Cynapsus Therapeutics Provides Clinical and Regulatory Update for APL-130277 for the Acute Rescue of OFF Motor Symptoms of Parkinson's Disease
Business Wire - Wed Mar 11, 3:10PM CDT
--Received Final Minutes From End-of-Phase 2 Meeting with U.S. FDA
CTH.TO: 21.50 (+0.05)

New Parkinson's drug cleared in Europe
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 9:23AM CST

ADMS: 19.93 (+0.50), ACOR: 33.07 (+0.14), NDRM: 22.41 (+0.26), XNPT: 7.14 (+0.25), IPXL: 43.35 (-0.29), ABBV: 59.35 (-0.23), TEVA: 63.66 (+1.62), SNY: 50.23 (+0.46), PRTA: 59.97 (+2.34)

Adamas' Lead Drug Targets Parkinson's Dyskinesia
Michael Hagan - at Seeking Alpha - Tue Feb 03, 4:53PM CST

IPXL: 43.35 (-0.29), ADMS: 19.93 (+0.50), ACOR: 33.07 (+0.14), NDRM: 22.41 (+0.26)

Cynapsus Therapeutics Inc. to Present at the D2 2015 - Noble Financial Capital Markets' Eleventh Annual Investor / Equity Conference
Business Wire - Thu Jan 15, 3:05PM CST
Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company, today announced that its President and CEO, Anthony Giovinazzo, will present at the Noble Financial Capital Markets' Eleventh Annual Equity Conference at Club Med in Sandpiper Bay, Florida, on Monday, January 19th at 10:00am Eastern Standard Time in Room 1.
CTH.TO: 21.50 (+0.05)

Medical Marijuana Goes To Market: Daniel Pearlstein Of M Partners
Life Sciences Report - at Seeking Alpha - Thu Jan 08, 10:42AM CST
Life sciences analyst Daniel Pearlstein of Toronto-based M Partners brings knowledge of the biotech sector and hands-on experience in the startup realm to understanding value and growth in small- and micro-cap life sciences companies. In this...
MNK: 82.08 (-0.92), AUPH: 3.36 (-0.03), HZNP: 28.99 (+0.41), GSK: 40.26 (+0.02), BMY: 59.22 (+0.47)

15 Biotech Names For 2015
Jason Napodano, CFA - at Seeking Alpha - Mon Jan 05, 1:37PM CST

NBIX: 54.09 (+0.53), NVIV: 10.54 (-0.19), LPCN: 18.04 (+0.58), EPRS: 5.88 (-0.35), DEPO: 27.33 (+0.35), ASPX: 100.96 (unch), BCLI: 3.20 (-0.06), CUR: 1.53 (+0.02)

First patient enrolled in Acorda Phase 3 PD trial
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 7:06AM CST

IPXL: 43.35 (-0.29), ADMS: 19.93 (+0.50), TEVA: 63.66 (+1.62), ACOR: 33.07 (+0.14), PRTA: 59.97 (+2.34), NDRM: 22.41 (+0.26)

Cynapsus Therapeutics Announces Uplisting to the Toronto Stock Exchange's Senior Equity Market
Business Wire - Tue Nov 25, 3:10PM CST
Cynapsus Therapeutics Inc. (TSX-V:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on Parkinson's disease, today announced that its common shares will commence trading on the Toronto Stock Exchange (TSX) as of the opening of trading on Friday, November 28, 2014. The Company's common shares will continue to trade under the symbol "CTH," with its common shares to cease trading on the TSX Venture Exchange concurrent with the commencement of trading on the TSX.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 326

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 292

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 0

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 31

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pony.ai & Toyota Launch 1,000 Gen-7 Robotaxis in China

Updated Category News Views 74

Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 117

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 419

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 216

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 160

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading

Top 5 Most Recently Viewed Articles

Inventiva's Significant Capital Boost Through Public Offering

Updated Category News Views 276

Inventiva's Upsized Public Offering Explained Inventiva, a clinical-stage biopharmaceutical company known for its focus on developing oral therapies targeting metabolic disorders, has recently announced the pricing details of its public offering. This significant initiative is set to raise around $150 million by selling approximately 38.96 million American Depositary...

Continue Reading
The Future of AI: How Innovations Drive Market Growth

Updated Category News Views 264

AI Market Growth Overview The artificial intelligence (AI) market is set for substantial growth, projected to increase by USD 237.4 billion from 2024 to 2028. The forecast indicates a remarkable compound annual growth rate (CAGR) of 30.07% during this period. This growth can largely be attributed to the rising demand for effective solutions in fraud prevention and the...

Continue Reading
commercetools Compilations: Innovations Driving Digital Growth

Updated Category News Views 177

Exciting Launch of commercetools Compilations commercetools has unveiled Compilations, a semi-annual showcase that highlights more than 50 product enhancements, demonstrating the organization’s dedication to innovation and improved customer experiences for users of the commercetools Platform. With over 13,000 deployments and 200 releases, this initiative significantly...

Continue Reading
AKOOL's Agentic Canvas: AI Execution Revolution

Updated Category News Views 23

AKOOL Elevates AI from Chat to Execution Well, folks, it looks like AKOOL is shaking things up in the world of artificial intelligence. Forget about AI that's just about chatting away and searching for answers like a digital gopher. This time, AKOOL is bringing something new to the table with its Agentic Canvas, and it's a real game-changer for anyone still fooling around...

Continue Reading
Qudian Inc. Transitions to High Templar Tech Limited

Updated Category News Views 222

Qudian Inc. Transitions to High Templar Tech Limited Qudian Inc., a technology-driven consumer company in China, has officially announced its rebranding to High Templar Tech Limited along with a change in its stock ticker from "QD" to "HTT". This significant decision reflects the company's evolving strategy and commitment to enhancing consumer experiences through...

Continue Reading